Medicinal Plants: Exploring Plant-Based Bioactive Compounds for Metabolic Diseases Prevention and Intervention
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Natural Products".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 590
Special Issue Editors
Interests: herbal medicine; infectious diseases; immunomodulation; diabetes
Interests: antimicrobial; biomedical applications; charecterization techniques; environment; health applications; green synthesis; silver nanoparticles; nanotechnology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The exploration of medicinal plants and their bioactive compounds has emerged as a promising frontier in the prevention and intervention of metabolic diseases. Metabolic disorders, such as diabetes mellitus, non-alcoholic fatty liver disease (NAFLD), and metabolic syndrome, pose significant health challenges globally, affecting millions of individuals and contributing to increased morbidity and mortality rates. Despite advancements in pharmacological treatments, the side effects and limitations of conventional drugs have spurred interest in alternative therapies derived from natural sources.
Medicinal plants offer a rich repository of bioactive compounds with potential therapeutic benefits. These natural compounds, including flavonoids, saponins, and polyphenols, have demonstrated efficacy in modulating key metabolic pathways, reducing oxidative stress, and improving insulin sensitivity. For instance, plants like Dioscorea spp. and constituents of the Mediterranean diet have shown promise in managing conditions such as diabetes and cardiovascular diseases through their anti-inflammatory and antioxidant properties.
The current body of research underscores the need for a deeper understanding of the mechanisms through which these plant-based compounds exert their effects. Studies have highlighted the role of these bioactives in enhancing beta cell function, regulating glucose metabolism, and modulating immune responses, thereby offering a multifaceted approach to disease management. Furthermore, the integration of these natural compounds into therapeutic regimens could complement existing treatments, providing a holistic approach to health promotion and disease prevention.
We invite researchers and authors to contribute to this journal’s Special Issue by sharing their insights and findings on the role of medicinal plants in metabolic disease management. Your contributions will help advance scientific discourse and pave the way for innovative, plant-based therapeutic strategies that address the growing burden of metabolic disorders.
Prof. Dr. Nceba Gqaleni
Dr. Suresh Babu Naidu Krishna
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metabolic diseases
- diabetes
- medicinal plants
- bioactives
- metabolic disorders
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
